Citation Impact
Citing Papers
Human autoimmune diseases: a comprehensive update
2015
The gut microbiota and host health: a new clinical frontier
2015 Standout
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
2014
Rheumatoid arthritis
2018 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Rheumatoid arthritis
2016 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Crohn's disease
2016 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Proposal for a new nomenclature of disease-modifying antirheumatic drugs
2013
Hidradenitis suppurativa
2020 Standout
Ulcerative colitis
2020 Standout
The changing landscape of biosimilars in rheumatology
2016
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
2014
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study
2016
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases
2017
The global burden of IBD: from 2015 to 2025
2015 Standout
The biosimilar road in inflammatory bowel disease: The right way?
2014
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
2015
Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence
2023 Standout
Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases
2017
Works of S. Shevchuk being referenced
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
2013
The prevalence and incidence of Systemic Lupus Erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan)
2013